CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Dexketoprofen Trometamol + Paracetamol +1 moredrug
Likely dose
Dexketoprofen Trometamol + Paracetamol 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06916234
NCT06916234Phase 4Completed
CompareCT.gov

Evaluation of the Analgesic Efficacy of the Combination of Dexketoprofen + Paracetamol and the Combination of Naproxen Sodium + Codeine in Patients With Acute Dental Pain

ibrahim doğru·interventional·Posted Apr 8, 2025·Updated Apr 8, 2025

In Brief

A Phase 4 clinical trial evaluating Dexketoprofen Trometamol + Paracetamol and Naproxen Sodium + Codeine Phosphate for Acute Dental Pain. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Acute dental pain is one of the most challenging conditions to treat and manage in dental practice. The aim of this study was to compare the efficacy of naproxen sodium + codeine phosphate (550/30 mg) and dexketoprofen trometamol + paracetamol (25/300 mg) in the treatment of acute dental pain in individuals with acute pericoronitis caused by impacted wisdom teeth.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Dental Pain
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedApr 8, 2025
Enrollment StartJan 10, 2023
Primary CompletionDec 20, 2023
Study CompletionJan 20, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 1.2 years ago

Interventions

Dexketoprofen Trometamol + Paracetamoldrug

Dexketoprofen Trometamol + Paracetamol (25mg + 300mg) is a NSAID. It was given to the patients twice a day.

Naproxen Sodium + Codeine Phosphatedrug

Naproxen Sodium + Codeine Phosphate (550mg + 30mg) is a NSAID. It was given to the patients twice a day.